1,355 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Philips Medical Systems Netherlands B.V. recalled 655 Azurion 7 B12 systems on January 26, 2026. The recall affects models 722067, 722225, and 722235 due to unexpected table movement when the Reset Geometry button is pressed. This poses a high risk of injury to patients and healthcare providers.
Philips Medical Systems recalled 1,979 Azurion 7 M12 Systems on January 26, 2026. The table may move unexpectedly when the Reset Geometry button is pressed, posing a high risk of injury. Healthcare providers and patients should stop using the devices immediately.
Asteria Health recalled 50,990 Estradiol pellets on January 26, 2026, due to potential metal particulate matter contamination. The recall affects products distributed nationwide in the USA. Consumers should stop using the pellets immediately and seek guidance from healthcare providers.
Asteria Health recalled 133 estradiol pellets on January 26, 2026, after detecting potential metal particulate matter. The recall, classified as Class II, affects pellets with lot number 253000126 and an expiration date of June 9, 2026. Consumers must stop using the product immediately and contact their healthcare provider for guidance.
Asteria Health recalled 1,699 sterile estradiol pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately and contact their healthcare provider for advice. The recall affects pellets distributed nationwide in the USA.
Asteria Health recalled 60,868 testosterone pellets on January 26, 2026, due to contamination risks. The recall affects specific lots of the product that may contain metal particulate matter. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Asteria Health recalled 1,631 sterile pellets of Testosterone and Triamcinolone Acetonide on January 26, 2026, due to potential metal contamination. Consumers should stop using the product immediately. This recall affects products distributed nationwide in the USA.
Asteria Health recalled 14,848 estradiol pellets on January 26, 2026, due to potential metal particulate contamination. Consumers and healthcare providers must stop using the product immediately. The recall is classified as Class II, indicating a high hazard level.
Asteria Health recalled 146 testosterone pellets on January 26, 2026, due to potential metal particulate matter. The recall affects products distributed nationwide in the USA. Consumers and healthcare providers must stop using the product immediately.
Asteria Health recalled 715 units of Estradiol, 37.5 mg pellets on January 26, 2026. The recall follows the potential presence of metal particulate matter in the product. Consumers should stop using the pellets immediately and contact their healthcare provider for further guidance.
Asteria Health recalled 4,599 testosterone pellets on January 26, 2026. The recall follows concerns over potential metal particulate matter contamination. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Asteria Health recalled 1,015 testosterone pellets on January 26, 2026 due to potential metal particulate contamination. The recall affects products distributed nationwide in the United States. Consumers must stop using the pellets immediately and contact their healthcare provider for guidance.
Asteria Health recalled 1,475 estradiol pellets on January 26, 2026, due to potential metal particulate contamination. This recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and seek guidance from their healthcare provider.
Asteria Health recalled 62,581 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately and contact their healthcare provider for guidance. The recall affects testosterone pellets with specific lot numbers and expiration dates.
Asteria Health recalled 89,074 testosterone pellets on January 26, 2026. The recall stems from potential metal particulate contamination. Consumers must stop using the product and contact their healthcare provider immediately.
Asteria Health recalled 153,498 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. The recall affects lots expiring between June and September 2026. Consumers and healthcare providers must stop using the product immediately.
Asteria Health recalled 194,336 testosterone pellets on January 26, 2026 due to potential metal contamination. Consumers must stop using the product immediately and contact their healthcare providers. The recall affects nationwide distribution in the USA.
Asteria Health recalled 2,442 units of Estradiol, 25 mg pellets on January 26, 2026. The recall follows the discovery of potential metal particulate matter in the product. Consumers must stop using the pellets immediately and consult their healthcare providers for guidance.
Asteria Health recalled 7,840 testosterone pellets on January 26, 2026, due to potential metal particulate matter contamination. Consumers must stop using the product immediately and contact healthcare providers for guidance. The recall affects products distributed nationwide in the USA.
Asteria Health recalled 1,758 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. The recall affects pellets distributed nationwide in the USA. Consumers should stop using the product immediately and contact their healthcare providers for guidance.
Asteria Health recalled 3,871 testosterone pellets on January 26, 2026, due to potential metal particulate matter. The recall affects products distributed nationwide in the USA. Consumers should stop using the product immediately and seek guidance from their healthcare providers.
Asteria Health recalled 100 sterile pellets of testosterone and anastrozole on January 26, 2026. The recall stems from potential metal particulate contamination. Consumers must stop using the product immediately and consult healthcare providers for guidance.
Asteria Health recalled 22,478 Estradiol 12.5 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers and healthcare providers must stop using the product immediately. The FDA classified this recall as Class II, indicating a high hazard level.
Asteria Health recalled 70,959 testosterone pellets on January 26, 2026, due to potential metal contamination. Consumers must stop using the product immediately. The recall affects multiple lots distributed nationwide in the USA.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.